User profiles for Jeannie Callum
Jeannie CallumQueen's University Verified email at sunnybrook.ca Cited by 13643 |
Transfusion of plasma, platelets, and red blood cells in a 1: 1: 1 vs a 1: 1: 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial
Importance Severely injured patients experiencing hemorrhagic shock often require massive
transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red …
transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red …
Acute kidney injury after cardiac surgery: focus on modifiable risk factors
Background— Acute kidney injury (AKI) after cardiac surgery is a major health issue.
Lacking effective therapies, risk factor modification may offer a means of preventing this …
Lacking effective therapies, risk factor modification may offer a means of preventing this …
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
The efficacy of convalescent plasma for coronavirus disease 2019 (COVID-19) is unclear.
Although most randomized controlled trials have shown negative results, uncontrolled studies …
Although most randomized controlled trials have shown negative results, uncontrolled studies …
[HTML][HTML] Age of transfused blood in critically ill adults
…, L Clayton, L McIntyre, J Callum… - … England Journal of …, 2015 - Mass Medical Soc
Background Fresh red cells may improve outcomes in critically ill patients by enhancing
oxygen delivery while minimizing the risks of toxic effects from cellular changes and the …
oxygen delivery while minimizing the risks of toxic effects from cellular changes and the …
Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial
Background: Cardiac surgery is frequently complicated by coagulopathic bleeding that is
difficult to optimally manage using standard hemostatic testing. We hypothesized that point-of-…
difficult to optimally manage using standard hemostatic testing. We hypothesized that point-of-…
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
…, M Egyed, G Benevolo, T Devos, J Callum… - The Lancet …, 2017 - thelancet.com
Background In the pivotal RESPONSE study, ruxolitinib, a Janus kinase (JAK)1 and JAK2
inhibitor, was superior to best available therapy at controlling haematocrit and improving …
inhibitor, was superior to best available therapy at controlling haematocrit and improving …
Essential role of patient blood management in a pandemic: a call for action
…, E Bisbe, AA Perez-Calatayud, J Callum… - Anesthesia & …, 2020 - journals.lww.com
The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19),
the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
Cryoprecipitate: the current state of knowledge
Cryoprecipitate is a diverse product containing factor VIII, von Willebrand factor, fibrinogen,
fibronectin, factor XIII, and platelet microparticles. The role of this complex product in the …
fibronectin, factor XIII, and platelet microparticles. The role of this complex product in the …
Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury
Importance Traumatic brain injury (TBI) is the leading cause of death and disability due to
trauma. Early administration of tranexamic acid may benefit patients with TBI. Objective To …
trauma. Early administration of tranexamic acid may benefit patients with TBI. Objective To …
A systematic review of transfusion-associated graft-versus-host disease
…, N DenHollander, WS Dzik, J Callum - Blood, The Journal …, 2015 - ashpublications.org
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of blood
transfusion. The clinicolaboratory features of TA-GVHD and the relative contributions of …
transfusion. The clinicolaboratory features of TA-GVHD and the relative contributions of …